Patients with PFIC2 with BSEP3 subtype mutations have higher incidence of HCC compared with less severe genotypes [4], necessitating careful screening in these patients via twice-yearly AFP tests and ultrasound [2,27]. This evidence concerns the gene AFP and hepatocellular carcinoma.